Evidence map›Paper›PMID 30065632›Full record

ArticleFrontiers in cellular neuroscience2018

Characteristic Metabolic Alterations Identified in Primary Neurons Under High Glucose Exposure.

Liangcai Zhao, Minjian Dong, Dan Wang, Mengqian Ren, Yongquan Zheng, Hong Zheng, Chen Li, Hongchang Gao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liangcai ZhaoSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Minjian DongSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Dan WangSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Mengqian RenSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Yongquan ZhengDepartment of Pharmacy, Women's Hospital, Medicine of School, Zhejiang University, Hangzhou, China.
Hong ZhengSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Chen LiSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Hongchang GaoSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Wenzhou Medical University · CNWomen's Hospital, School of Medicine, Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive dysfunction is a central nervous system (CNS) complication of diabetes mellitus (DM) that is characterized by impaired memory and cognitive ability. An in-depth understanding of metabolic alterations in the brain associated with DM will facilitate our understanding of the pathogenesis of cognitive dysfunction. The present study used an

Indexed as

ATPhigh glucosemetabonomicsneuronnuclear magnetic resonance

Identifiers

PMID30065632
PMCPMC6056731
OpenAlexW2884396167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.